Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iqvia Holdings Inc (NY: IQV )

229.26 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Iqvia Holdings Inc

< Previous 1 2 3 4 5 6 7 Next >
Where IQVIA Hldgs Stands With Analysts
Via Benzinga
IQVIA Clocks 2.8% Sales Growth In Q4, Beats Street View By A Whisker
Via Benzinga
PayPal, Global Payments And 3 Stocks To Watch Heading Into Friday
With US futures trading mixed this morning on Friday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Investor Optimism Declines Slightly As Dow Drops 250 Points
The CNN Money Fear and Greed index showed some decline in the overall sentiment among US investors. US stocks closed lower on Thursday as investors assessed recent batch of corporate earnings. 
Via Benzinga
Earnings Outlook For IQVIA Holdings
Via Benzinga
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
These companies are changing their industries. 
Via The Motley Fool
Will Investors Notice Exciting Sign On IQVIA Hldgs's Chart?
Via Benzinga
Analyst Ratings for IQVIA Hldgs
Via Benzinga
Expert Ratings for IQVIA Hldgs
Via Benzinga
Where IQVIA Hldgs Stands With Analysts
Via Benzinga
Analyst Ratings for IQVIA Hldgs
Via Benzinga
8 Analysts Have This to Say About IQVIA Hldgs
IQVIA Hldgs (NYSE:IQV) has observed the following analyst ratings within the last quarter: 
Via Benzinga
7 Analysts Have This to Say About IQVIA Hldgs
Analysts have provided the following ratings for IQVIA Hldgs (NYSE:IQV) within the last quarter: 
Via Benzinga
World Wrestling Entertainment To Rally Around 12%? Here Are 10 Other Analyst Forecasts For Tuesday
Goldman Sachs boosted the price target for The Wendy's Company (NASDAQ: WEN) from $22 to $25. Goldman Sachs analyst Jared Garber maintained a Neutral rating on the stock. Wendy's shares fell 1.4% to... 
Via Benzinga
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
These healthcare companies' revenue and earnings have grown, and they expect more growth. 
Via The Motley Fool
Veracyte Stock Showing Market Leadership; Earns 93 RS Rating
Veracyte shows rising price performance, earning an upgrade to its IBD Relative Strength Rating. 
Via Investor's Business Daily
Target To Rally 29%? Plus This Analyst Predicts $245 For IQVIA Holdings
Piper Sandler boosted the price target on Target Corporation (NYSE: TGT) from $190 to $200. Target shares fell 13.1% to close at $155.47 on Wednesday. 
Via Benzinga
General Electric To Rally Around 14%? Here Are 5 Other Price Target Changes For Thursday
  Morgan Stanley raised General Electric Company (NYSE: GE) price target from $85 to $88. Morgan Stanley analyst Joshua Pokrzywinski maintained the stock with an Overweight rating. GE shares rose 2.2%... 
Via Benzinga
Expert Ratings for IQVIA Hldgs
Analysts have provided the following ratings for IQVIA Hldgs (NYSE:IQV) within the last quarter: 
Via Benzinga
6 Analysts Have This to Say About IQVIA Hldgs
Analysts have provided the following ratings for IQVIA Hldgs (NYSE:IQV) within the last quarter: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022
Via Benzinga
IQVIA: Q3 Earnings Insights
IQVIA Hldgs (NYSE:IQV) reported its Q3 earnings results on Wednesday, October 26, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings IQVIA Hldgs beat estimated... 
Via Benzinga
What 5 Analyst Ratings Have To Say About IQVIA Hldgs
Within the last quarter, IQVIA Hldgs (NYSE:IQV) has observed the following analyst ratings: 
Via Benzinga
5 Analysts Have This to Say About IQVIA Hldgs
Within the last quarter, IQVIA Hldgs (NYSE:IQV) has observed the following analyst ratings: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022
Upgrades 
Via Benzinga
Medpace Earnings Are 'Almost Unbelievable'; MEDP Stock Flies
Medpace earnings soared in Q3 as weakness in contract awards turned to strength, sending MEDP stock surging. 
Via Investor's Business Daily
Biosimilars Are Revolutionizing Healthcare: Is This Industry Leader a Buy?
Biosimilars are bringing down prescription drug costs without sacrificing quality. 
Via The Motley Fool
Tesla To $370? Plus HC Wainwright Slashes PT On This Stock By 67%
HC Wainwright & Co. cut KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) price target from $48 to $16. KalVista Pharmaceuticals shares fell 1.8% to $5.06 in pre-market trading. 
Via Benzinga
Peering Into IQVIA's Recent Short Interest
IQVIA Hldgs (NYSE:IQV) short percent of float has fallen 20.35% since its last report. The company recently reported that it has 1.67 million shares sold short, which... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
Upgrades 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.